Advisor Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $1.95M | Sell |
39,008
-4,828
| -11% | -$241K | 0.01% | 828 |
|
|
2019
Q3 | $1.96M | Sell |
43,836
-98
| -0.2% | -$4.37K | 0.01% | 774 |
|
|
2019
Q2 | $1.82M | Sell |
43,934
-687
| -2% | -$28.4K | 0.01% | 797 |
|
|
2019
Q1 | $1.8M | Sell |
44,621
-22,976
| -34% | -$928K | 0.01% | 763 |
|
|
2018
Q4 | $2.57M | Buy |
67,597
+4,833
| +8% | +$184K | 0.03% | 536 |
|
|
2018
Q3 | $2.48M | Buy |
62,764
+4,570
| +8% | +$181K | 0.03% | 569 |
|
|
2018
Q2 | $2.04M | Sell |
58,194
-10,414
| -15% | -$365K | 0.03% | 542 |
|
|
2018
Q1 | $2.4M | Sell |
68,608
-8,696
| -11% | -$304K | 0.03% | 490 |
|
|
2017
Q4 | $2.68M | Buy |
77,304
+2,183
| +3% | +$75.7K | 0.04% | 456 |
|
|
2017
Q3 | $2.55M | Buy |
75,121
+11,982
| +19% | +$406K | 0.04% | 422 |
|
|
2017
Q2 | $2.15M | Buy |
63,139
+1,399
| +2% | +$47.7K | 0.04% | 459 |
|
|
2017
Q1 | $1.92M | Buy |
61,740
+9,563
| +18% | +$298K | 0.04% | 476 |
|
|
2016
Q4 | $1.43M | Sell |
52,177
-6,996
| -12% | -$191K | 0.03% | 523 |
|
|
2016
Q3 | $1.94M | Buy |
59,173
+7,213
| +14% | +$237K | 0.05% | 413 |
|
|
2016
Q2 | $1.57M | Buy |
+51,960
| New | +$1.57M | 0.04% | 451 |
|